Developing novel treatment options to chronic conditions based on stem cell technologies. Optimization of lead candidates on statistically significant patient derived platforms to develop the blockbuster drug molecules for Alzheimer's/Parkinson's diseases.
Founder: Dr Suba Dravida, PhD
Experimentalist turned entrepreneur having founded Transcell Biologics and successfully running profitable subsidiary (biobank); commercialized 3 cell based products; lead research teams working on Chronic diseases and Oncology. She has over 20 patents to her credit and is published in peer reviewed science journals.
Working on the optimization of lead candidates on statistically significant patient derived platforms to develop the blockbuster drug molecules forAlzheimer's/Parkinson's diseases.